SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Chiron
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
23 0 0 CHIR
Emcee:  shannon Type:  Unmoderated
Introduction Market Data Compact
Where is this stock going from here? There hasn't been much news (other than earnings) which didn't do much for it. Does anyone have any insight?
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
23 Chiron Fundamentals: You get them at: www2.marketguide.com I think Chiron isSpekulatius-11/28/1996
22 Hello Shannon, do you follow CHIR closely? I am interested to buy some at theseali foughi-11/27/1996
21 What's going on with CHIRON I would have figured the stock to increase due shannon-7/9/1996
20 chiron a buy @ 99 1/2 they are going to split 4 for 1 and just received fda appEddy Hagan-6/11/1996
19 This weeks Barron's expects price of stock in both companies to open up firvinod Khurana-6/8/1996
18 Cephalon was allowed to go through today...... this should provide some upside shannon-6/8/1996
17 i thought i posted this yesterday - but visiting again today i see its not olduser-5/22/1996
16 Chiron Fans - You may want to look at Genome Therapeutics Corp. thread. Also iTara Cobble-5/20/1996
15 Today announcement of the 4-1 split should help your position tremendously. ChiKeith Fauci-5/20/1996
14 Vinod Excellent Observation,I am short the june 100 puts.I took in $8.75 per sholduser-5/19/1996
13 Chiron may be worth keeping an eye on based on these technical facts: 1) The svinod Khurana-5/17/1996
12 SEC Sues Nevada Man For Insider Trading On 1994 Mergers NEW YORK (Dow Jones)-vinod Khurana-5/17/1996
11 Ribozyme Pharma Gets Review Exemption From NIH Panel BOULDER, Colo. (Dow Jonevinod Khurana-5/17/1996
10 Chiron Corp. 1Q Net 29c A Share Vs Loss $9.64 On Chgs Chiron Corp. (CHIR) vinod Khurana-5/17/1996
9 Health Brief -- CHIRON CORP.: Profit Totals $12.7 Million, Reversing Year-Earlvinod Khurana-5/17/1996
8 Chiron Corp, Ciba Pharma, Focal Inc In Collaboration Pact SUMMIT, N.J. (Dow Jvinod Khurana-5/17/1996
7 Business Brief -- CHIRON CORP.: Focal, Ciba Pact to Create Drug-Delivery Technvinod Khurana-5/17/1996
6 FDA Sets June 7 Review Of Cephalon/Chiron's Myotrophin WEST CHESTER, Pa. vinod Khurana-5/17/1996
5 Fate Of Cephalon's Gehrig Disease Drug To Be Settled Soon By Jesse Eisingvinod Khurana-5/17/1996
4 Nabi Inc. Starts Production Of CMV Disease-Preventing Drug BOCA RATON, Fla. (vinod Khurana-5/17/1996
3 FDA Clears HIV Home Test Sys Developed By J&J Unit WASHINGTON (Dow Jones)vinod Khurana-5/17/1996
2 Cephalon Inc. Sees Year Revs 'Substantially' Lower Than '95 WASHIvinod Khurana-5/17/1996
1 Chiron Corp.....the month in review Cephalon Inc. Sees Year Revs 'Subvinod Khurana-5/17/1996
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News